Par Shareholders to Receive $50.00 per Share in Cash; Fully Diluted Equity Value of $1.9 Billion WOODCLIFF LAKE, N.J., July 16, 2012 (CRWENewswire) — Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it has entered into a definitive merger agreement to be acquired by an affiliate of c in a transaction with an equity value [...]
↧